Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies



Rating:

Share or cite this content

Citations should be made in the following way:
S. Škrgat (Ljubljana, Slovenia), M. Kopac (Ljubljana, Slovenia), M. Rijavec (Golnik, Slovenia), U. Bidovec Stojkovic (Golnik, Slovenia), I. Kern (Golnik, Slovenia), R. Vantur (Golnik, Slovenia), P. Korošec (Golnik, Slovenia). Heterogeneous response of airway eosinophilia to biologics in severe asthma patients. 3730

Member's Comments

No comment yet.

Related content which might interest you: Factors driving airway eosinophilia in prednisone-dependent severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Airway autoimmunity and response to a 14-day course of oral corticosteroids in patients with severe eosinophilic asthma Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020 Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Maximal airway response in patients with asthma and cough variant asthma Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis Year: 2007 IL-33 in patients with severe uncontrolled allergic asthma Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Relationship between bronchial hyperresponsiveness and response to β2-agonists in steroid-naïve patients with mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 503s Year: 2002 Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD> Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 Mast cells are associated with exacerbations and eosinophilia in children with severe asthma Source: Eur Respir J 2016; 48: 1320-1328 Year: 2016 Clinical response to mepolizumab in patients with severe eosinophilic asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Role of neutrophils in airway inflammation in children with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 Improved small airway function by benralizumab in patients with severe eosinophilic asthma Source: Virtual Congress 2020 – From respiratory physiology to clinical practice: exercise and respiratory muscles Year: 2020 Small airways disease evaluation in patients with mild/moderate asthma and correlation with bronchial hyperresponsiveness and disease control Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Persistent airway inflammation in young allergic wheezing children treated with inhaled corticosteroids Source: Annual Congress 2003 - Current issues on wheezing in infancy Year: 2003